Dianthus Therapeutics Inc.(DNTH:US)

Market Cap$3.95B

Key Metrics

Price$72.09

Revenue (TTM)$1.9M

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$192.25M

EBITDA (TTM)-$217.72M

Op. Margin (TTM)-11.44K%

Dividend Yield-

Holders Yield-

Cash on hand$110.55M

Total Assets$1.213B

Net Assets$1.172B

Total Debt$1.29M

Dianthus Therapeutics Inc.(DNTH:US)

Market Cap$3.95B

Price history

Key Metrics

Price$72.09

Revenue (TTM)$1.9M

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$192.25M

EBITDA (TTM)-$217.72M

Op. Margin (TTM)-11.44K%

Dividend Yield-

Holders Yield-

Cash on hand$110.55M

Total Assets$1.213B

Net Assets$1.172B

Total Debt$1.29M

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
$761K$463K$284K$396K$193K$1.16M$1.33M$2.17M$1.86M$874K$457K$924K$969K$476K$1.18M$1.17M
Cost of Revenue
----------------
Gross Profit
----------------
$62.24M$47M$69.83M$40.68M$35.12M$34.34M$33.24M$32.07M$24.07M$18.72M$13.41M$16.68M$12.75M$8.16M$11.87M$9.43M
Research and Development$48.69M$34.53M$59.9M$32.49M$26.25M$27M$26.41M$25.54M$18.07M$13.08M$8.78M$7.96M$10.25M$5.85M$9.83M$7.22M
Selling, General, and Administrative$13.56M$12.47M$9.93M$8.2M$8.87M$7.34M$6.83M$6.53M$6M$5.64M$4.63M$8.72M$2.49M$2.31M$2.04M$2.21M
Other Operating Expenses----------------
Operating Income
-$61.48M-$46.53M-$69.54M-$40.29M-$34.93M-$33.18M-$31.92M-$29.9M-$22.2M-$17.84M-$12.96M-$15.76M-$11.78M-$7.68M-$10.69M-$8.25M
$11.27M$5.7M$5.11M$3.52M$3.3M$3.67M$3.48M$4.73M$4.6M$4.1M$2.39M$996K$636K$594K$577K$470K
Non-Operating Interest Income$11.54M$6.27M$5.27M$3.66M$3.4M$3.79M$3.99M$4.45M$4.71M$4.22M$2.44M$1.03M$687K$606K$640K$416K
Non-Operating Interest Expense----------------
Other Income/Expense-$275K-$566K-$158K-$135K-$105K-$125K-$514K$281K-$111K-$126K-$51K-$31K-$51K-$12K-$63K$54K
Income Before Tax
-$50.22M-$40.83M-$64.43M-$36.77M-$31.63M-$29.51M-$28.44M-$25.17M-$17.61M-$13.75M-$10.56M-$14.76M-$11.14M-$7.09M-$10.12M-$7.78M
Income Tax
----------------
Net Income
-$50.22M-$40.83M-$64.43M-$36.77M-$31.63M-$29.51M-$28.44M-$25.17M-$17.61M-$13.75M-$10.56M-$14.76M-$11.14M-$7.09M-$10.12M-$7.78M
Minority Interests
----------------
Preferred Stock Dividends
----------------
Net Income to Common
-$50.22M-$40.83M-$64.43M-$36.77M-$31.63M-$29.51M-$28.44M-$25.17M-$17.61M-$13.75M-$10.56M-$14.76M-$11.14M-$7.09M-$10.12M-$7.78M
Shares Outstanding (Basic)
56.03M48.03M44.97M37.79M35.82M35.79M35.03M34.24M34.23M25.67M-3.91M14.82M14.82M-14.82M
Shares Outstanding (Diluted)
56.03M48.03M44.97M37.79M35.82M35.79M35.03M34.24M34.23M25.67M-3.91M14.82M14.82M-14.82M
EPS (Basic)
-$0.90-$0.85-$1.43-$0.97-$0.88-$0.82-$0.81-$0.74-$0.51-$0.54--$3.78-$0.75-$0.48--$0.53
EPS (Diluted)
-$0.90-$0.85-$1.43-$0.97-$0.88-$0.82-$0.81-$0.74-$0.51-$0.54--$3.78-$0.75-$0.48--$0.53
EBIT
-$61.48M-$46.53M-$69.54M-$40.29M-$34.93M-$33.18M-$31.92M-$29.9M-$22.2M-$17.84M-$12.96M-$15.76M-$11.78M-$7.68M-$10.69M-$8.25M
EBITDA
-$61.47M-$46.14M-$69.7M-$40.41M-$34.83M-$33.02M-$31.71M-$30.04M-$22.06M-$17.73M-$12.82M-$15.66M-$11.66M-$7.59M-$10.62M-$8.31M